EZETIMIBE\PITAVASTATIN: 21 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
21
Total FAERS Reports
1 (4.8%)
Deaths Reported
13
Hospitalizations
21
As Primary/Secondary Suspect
Active Ingredient: EZETIMIBE\PITAVASTATIN CALCIUM ·
First Report: 20230101 · Latest Report: 20250501
What Are the Most Common EZETIMIBE\PITAVASTATIN Side Effects?
#1 Most Reported
Renal impairment
2 reports (9.5%)
#2 Most Reported
Loss of consciousness
2 reports (9.5%)
#3 Most Reported
Weight increased
1 reports (4.8%)
All EZETIMIBE\PITAVASTATIN Side Effects by Frequency
No side effect data available.
Who Reports EZETIMIBE\PITAVASTATIN Side Effects? Age & Gender Data
Gender: 47.8% female, 52.2% male. Average age: 66.0 years. Most reports from: KR. View detailed demographics →
Is EZETIMIBE\PITAVASTATIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2023 | 15 | 1 | 10 |
| 2024 | 3 | 0 | 2 |
| 2025 | 1 | 0 | 0 |
What Is EZETIMIBE\PITAVASTATIN Used For?
| Indication | Reports |
|---|---|
| Hypercholesterolaemia | 10 |
| Dyslipidaemia | 5 |
Official FDA Label for EZETIMIBE\PITAVASTATIN
Official prescribing information from the FDA-approved drug label.